Photo: DSM
Photo: DSM

Peptidoglycans – Snicking away at animal performance

dsm-firmenich
dsm-firmenich Partner profile
21-02-2018 | | |
Photo: DSM
Photo: DSM

As animal production becomes more and more sophisticated, previously unobserved factors that potentially hinder performance become a bigger issue. Intestinal commensal bacteria – bacteria that live together – fit this narrative.

Cell walls of non-pathogenic gram-negative bacteria are mostly lipopolysaccharides. Peptidoglycans (PGN), or murein, are primary components of gram-positive bacteria. In normal intestinal bacteria, neither class causes disease. But fragments of their cell walls which remain in the intestine as ‘intestinal waste’ can push performance downward.

This is particularly the case with PGN – a thread that unites bacteria of virtually all types, regardless of species, type, or any other classification. While necessary for the survival of bacteria, PGN can snick away at bird performance and profits and not be noticed.

What is a Peptidoglycan?

PGN is a massive polymer of amino acids (e.g., peptido-) and sugars (e.g.,-glycan) unique to bacterial cell walls. The carbohydrate or sugar constituents alternate from B-(1,4)-linked N-acetylglucosamine (NAG) to N-acetylmuramic acid (NAM) cross-linked by short peptides (Figure 1). Amino acids meld into a 2- or 3-dimensional lattice to reinforce and give strength. PGN provides the bacteria with structural support against osmotic pressure.

Figure 1. Structure of a peptidoglycan polymer.

PGN undergoes constant growth and division in a manner similar to bone reconstruction in animals. As much as a 50% turnover of PGN occurs within one generation, according to researchers. This PGN remains in the spent growth media and probably mimics a similar phenomenon in the intestinal lumen.

Peptidoglycan exposure levels

In gram-positive (G+) bacteria, PGN is about 90% of the dry weight (Figure 2). G+ bacteria predominate in the intestinal tract. In the turkey microbiome, for example, 77% of the microbes were G+ rods, while 14% were G-, and 9% were G+ cocci. In healthy swine, 71% of microbes were G+. This shows that G+ bacteria exist at a disproportionately higher level in the intestinal tract.

Figure 2. Gram-positive bacteria have a thick layer of peptidoglycan (PGN), shown in red, outside the membrane. Gram-negative bacteria have significantly less PGN inside the membranes.

Natural bacterial cell death generates an abundant source of PGN in the intestine. In one study, 34% of total fresh faecal bacteria was classified as dead. In another, 32% of fresh faecal bacteria was dead, while an additional 20% was “injured.” And although G+ lactococci are resistant to gastric acidity (90 to 98% survival), only 10 to 30% survive the duodenum. In fact, 60% of the faeces mass is comprised of bacteria.

Airborne PGN can be abundant in animal production facilities and grain processing plants. PGN carried on dust particles is common in swine farrowing and nursery production units. The repetitive exposure of these aerial organic dust particles can be debilitating to lung function in mice, according to Nebraska research.

When airborne sources are added to the G+ bacteria in the intestinal tract, where 90% of the cell wall is PGN and 30 to 35% of cells are dead, exposure to this cellular “waste” is quite high. It is this constant source of waste that can physically interfere with normal intestinal enzyme-substrate functions.

The high cost of excessive mucin secretion

Intestinal mucous protects against potential pathogens and toxins, and impedes their entry into the blood stream. There has been a growing recognition that PGN and lipopolysaccharides act as intestinal antagonists and stimulate mucin secretion. This can adversely affect animal performance efficiency via the intestinal mucous barrier.

For example, about one-third of the amino acid content of mucin is threonine. The gastrointestinal requirement for most essential amino acids is 14 to 33% – but for threonine, this jumps to 61% for gut-related functions and mucin production. Swine research finds insufficient dietary threonine restricts intestinal mucin secretion. Because mucin is essentially indigestible to the host, mucin represents a net nitrogen loss to the animal. Thus, excessive mucin synthesis and secretion fuelled by antagonists like PGN is nutritionally costly.

In the end

The greatest threats to efficient and profitable animal performance are those that go unobserved. They allow stressors to secretly chip away at normal body processes, diverting nutrients away from growth and efficiency. Peptidoglycans fit this category.

Authors: N.E. Ward and A. Cowieson, DSM Nutritional Products

dsm-firmenich
dsm-firmenich Partner profile

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavours, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. More about dsm-firmenich  

dsm-firmenich
dsm-firmenich Partner profile

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavours, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. More about dsm-firmenich  

Beheer